Blue Horizon Charitable Foundation was represented at the World Bank and International Monetary Fund Annual Meetings in DC. This year’s events took place in Washington, D.C. from October 14-20, 2019. Katarina Novakova, Director of Relations at Blue Horizon Charitable Foundation [...]

Clinical trials are research investigations that play an important role in the development of health information and research for public health care. Clinical trials guiding principles are based on maximum benefit and minimal risk to the participants enrolled in a [...]

BHI Therapeutic Sciences (BHITS) has been invited to present its abstract, “A retrospective chart review study of allogeneic umbilical cord blood mononuclear cell therapy for stroke,” at the German Stem Cell Network’s 7th Annual GSCN Conference being held Sept. 23-25 at the Max Delbruck [...]

Blue Horizon International Therapeutic Sciences to exhibit at World Congress on Anti-Aging Medicine in Las Vegas   BHI Therapeutic Sciences (BHITS), BHI Rejuve and Alpha Blu Skin Care will participate in the 26th World Congress on Anti-Aging Medicine & Exhibition [...]

BHI Therapeutic Sciences (BHITS), a leader in stem cell therapy and research utilizing human umbilical cord blood, announced today that the company has been notified by the Food and Drug Administration (FDA) that its Investigational New Drug (IND) application to [...]

Anton Antipov, an International Federation of Body Building and Fitness (IFBB) professional physique champion and fitness model, recently visited BHI Slovakia, stem cell research and treatment center, where he was named an ambassador for the healthcare organization. Mr. Antipov is [...]

BHI Therapeutic Sciences (BHITS) and Brian Mehling, M.D. hosted a private screening of Stem Cells: The Next Frontier on Tuesday, February 13 in New York. The evening included a Q & A session and information on how to participate by [...]

The 2018 World Economic Forum (WEF) in Davos explored the ideas, innovations and discoveries that are reshaping our world by working closely with those in the vanguard of change from such fields as the arts, culture, engineering, media, medicine, science, [...]

FOUNDER OF BLUE HORIZON INTERNATIONAL AVAILABLE TO DISCUSS BREAKTHROUGHS IN STEM CELL RESEARCH   ZURICH, Switzerland – January 18, 2017 – Dr. Brian Mehling, world-renowned stem cell researcher, board-certified orthopedic trauma surgeon, and founder of Blue Horizon International (BHI), will be [...]

Brian Mehling, M.D. is a keynote speaker at the 6th International Conference on Tissue Engineering and Regenerative Medicine. The conference will be held in San Francisco, August 23-24 and its focus is on the importance of tissue engineering and regenerative medicine to [...]